Moderna has submitted all the documents for full approval of its vaccine in the United States

The U.S. Food and Drug Administration approved Pfizer and BioNTech vaccines on August 23.

The American company Moderna has sent all the necessary documentation to obtain full approval of its coronavirus vaccine by the U.S. Food and Drug Administration (FDA). The company’s press service announced this.

“Moderna announced the completion of the application process to the FDA for full licensing of the COVID-19 vaccine for persons over the age of 18,” the message reads. The company also noted that they asked the medical regulator to consider the company’s application as a priority and requested certification for using their drug in emergency circumstances for children 12 years and older.

Last Monday, the FDA finally approved using a coronavirus vaccine developed by the American company Pfizer and its German partner BioNTech. Pfizer’s drug is the first COVID-19 vaccine that has received final approval from the department. In December last year, the regulator certified Pfizer’s vaccine under an accelerated procedure for use in emergencies. Similar approval was later received by Moderna and Johnson & Johnson vaccines.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Author: Ivan Maltsev
The study of political and social problems of different countries of the world. Analysis of large companies on the world market. Observing world leaders in the political arena.
Function: Chief-Editor
Ivan Maltsev

Spelling error report

The following text will be sent to our editors: